Hosted by


Associate Professor Andrea Cheville


Mayo Clinic, USA

Dr. Cheville is a clinician researcher committed to developing cost-sensitive methods to optimize the function, experience and quality of life of patients with chronic conditions, particularly cancer and lymphedema. She received her MD degree from Harvard Medical School and a Masters in Clinical Epidemiology from the University of Pennsylvania. Following advanced training in Pain and Palliative Care at Memorial Sloan Kettering Cancer Center, she founded and directed the Cancer Rehabilitation and Lymphedema Program at the University of Pennsylvania’s Abramson Family Cancer Institute. Currently, she serves as the Research Chair and Division Chair for Cancer Rehabilitation and Lymphedema Services in the Department of Physical Medicine and Rehabilitation at the Mayo Clinic in Rochester, MN. Her research into collaborative telecare and outcomes measurement is funded by the US National Institutes of Health. Dr. Cheville serves on multiple credentialing, advisory, and professional organizations, including serving for 10 years on the Board of the Lymphology Association of North America. She was recently elected to the National Academy of Medicine, formerly the Institute of Medicine.

Assistant Professor Jie Deng


University of Pennsylvania, USA

Dr. Jie Deng is an Associate Professor at the University of Pennsylvania, School of Nursing. Dr. Deng has centered her work around an under-recognized, under-studied late effect of head and neck cancer therapy: Lymphedema. She has been funded by the NIH/NIDCR, NCI, American Cancer Society, Oncology Nursing Society Foundation, and other sources to examine lymphedema. She has conducted pioneering research projects in identifying the scope and impact of head and neck lymphedema as well as developing clinical measurement tools. Her work has filled critical gaps in this area that facilitate healthcare providers in scientifically understanding, assessing, and managing this late effect. She has published in many prestigious international journals and disseminated her findings at numerous national and international professional conferences. Her research findings have been adopted into the American Society Head and Neck Cancer Survivorship Care Guideline (2016). Her work is recognized and implemented by clinicians in the United States and other countries. The impact of Dr. Deng’s work in oncology nursing and lymphedema management is evident as she has been selected as a leader in several national organizations. She was the Chair of the 2016 National Lymphedema Network International Conference.

Dr Malou van Zanten


Molecular and Clinical Research Institute St George’s Hospital, University of London, UK

Dr van Zanten was previously Research Officer at the Lymphoedema Clinical Research Unit, Department of Surgery, Flinders University, South Australia. She has a Bachelor of Health in Skin Therapy (Allied Health Professional) from the University of Applied Science, Utrecht, The Netherlands. Following her relocation to South Australia, she obtained her PhD in 2016. Her PhD thesis, titled: “Imaging the superficial lymphatic system of the lower limb after soft tissue injury” describes the lymphatic drainage pathways in and around soft tissue reconstructions. She has an interest in lymphoedema treatment, scar tissue, lymphatic imaging, early diagnosis and prevention.

Jan Rice


Woundcare Services, Australia

Jan trained at The Alfred hospital and progressed through various training programs to eventually study Plastic Surgery Nursing. This led her into wound management in a formal sense in 1993 when she joined Wound Foundation of Australia. Since then Jan has been training in wound management for Monash University, La Trobe University and Training Beyond 2000. She has authored many short papers on wound management and co-authored book chapters and a training manual in plastic surgical nursing. Jan has worked on many advisory boards and been a member of many committees focused on wound care. She holds a Masters in Wound Care, and now runs her own consultancy business- Jan Rice WoundCareServices Pty Ltd- which sees her consulting in aged care, acute private surgical hospitals and private homes. Since 2006 Jan has also run a wound clinic at Ashwood Medical Group in Ashburton, Melbourne. Over 30 years of specific wound training, Jan has been an invited speaker at many State, National and International conferences and wound meetings.

Dr Echoe Bouta


Outcome Capital, Boston, USA

Echoe Bouta is a biomedical engineer focused on understanding the role of the lymphatic system in multiple disease states and determining the therapeutic potential of targeting lymphatics. She started her research career as an undergraduate student on a project testing potential lymphedema treatments. Her PhD thesis work at University of Rochester focused on elucidating the role of lymphatics in inflammatory arthritis in an effort to develop lymphatic-targeting therapies. Keeping with this research theme, her recent project as a research fellow at Massachusetts General Hospital focuses on understanding the relationship between adipose tissue, lymphatic capability, and immune function to catalyze more effective therapies for lipedema. The goal of this research research was to provide critical knowledge about the etiology of lipedema and test potential therapies targeting lymphatic function.

Register Now

Key Dates

  • Call for Abstracts opens1 June 2017
  • Closing Date for Receipt of Abstracts10 November 2017
  • Registration opens20 November 2017
  • Notification of acceptance of abstract11 December 2017
  • Early bird Registration Closes2 February 2018
  • Accommodation booking deadline2 April 2018
  • Pre-Conference Workshops16 May 2018
  • 12th ALA Conference17-19 May 2018
  • Post-Conference Workshops20 May 2018